Indefinite Delivery Contract HHSN271201600004I

The federal contract IDV award HHSN271200800009C was a single award indefinite delivery contract issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $2,162,027.85 contract, awarded to Duke University's Office of Research Administration, provided funding for an MTA study related to the National Institute of Mental Health (NIMH). This IDV did not have any set-aside designations. The period of performance extended from the...

This indefinite delivery contract, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Duke University, aims to support the Best Pharmaceuticals for Children Act - Pediatric Trials Network (BPCA-PTN) program. The $96,000,000 contract has an ultimate completion date of June 3, 2026 and does not utilize any set-aside designations. Under this IDV, Duke University's Office of Research Administration Division is the prime contractor and will...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Duke University's Office of Research Administration Division to support Phase 0 through Phase II clinical trials of investigational products against infectious diseases. The IDIQ contract, valued at up to $346,610,277, has a performance period from January 14, 2022 to January 13, 2032. Under this IDIQ, Duke...

The University of Exeter was awarded a single-award Indefinite Delivery Contract (IDC) valued at $1,988,692 by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services. The IDC, awarded in February 2024, has a 30-month ordering period and enables the agency to issue task orders for the university to conduct clinical evaluations of an extended controlled release tablet formulation of Phenserine tartrate for use in the treatment of early mild...

This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Duke University's Office of Research Administration Division as the prime contractor. The $20,000,000 IDC falls under the NIAID Animal Models of Infectious Diseases 2010-2017 multiple-award IDIQ contract vehicle and does not have any set-aside designations. Under this IDC, Duke University will...

This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery,...

The National Institutes of Health National Institute of Child Health and Human Development awarded a multiple award IDV to various contractors to conduct clinical trials in support of contraceptive development and the Contraceptive Clinical Trials Network for female sites. Task orders were issued to the University of California, Davis for protocol finalization and start-up of the Ovaprene vaginal device clinical trial, as well as to provide assistance with protocol review and development...

This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to the University of California, Irvine (UCI) to provide funding for an MTA (Mental Health Treatment Allocation) study. The $2,622,695.23 single-award IDC has a period of performance ending on March 31, 2013. As a large research university and member of the Association of American Universities, UCI leverages its extensive...

The Defense Advanced Research Projects Agency (DARPA) awarded Duke University an Other Transaction (OT) indefinite delivery vehicle (IDV) contract called MEASQUIT, valued at $1,000,000, to provide research and development services related to measurement-based quantum information and transduction. This award does not have any set-aside designations. Duke University's Office of Research Administration Division is the prime contractor for this IDV. The full scope of services Duke will provide under...

This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to provide comprehensive early phase clinical trial services. The $346.6 million contract, titled "Early Phase Clinical Trial Units (EPCTU)", facilitates Phase 0 through Phase II trials of investigational products against infectious diseases over a 10-year ordering period from...